Aadi Bioscience CEO Stephen Hoffman's 2018 pay falls 30% to $1.4M
Aadi Bioscience reports 2018 executive compensation
By ExecPay News
Published: April 27, 2020
Aadi Bioscience reported fiscal year 2018 executive compensation information on April 27, 2020.
In 2018, five executives at Aadi Bioscience received on average a compensation package of $876K, a 23% decrease compared to previous year.
Average pay of disclosed executives at Aadi Bioscience
Stephen Hoffman, Chief Executive Officer, received $1.4M in total, which decreased by 30% compared to 2017. 46% of Hoffman's compensation, or $667K, was in option awards. Hoffman also received $306K in non-equity incentive plan, $470K in salary, as well as $1.1K in other compensation.
Joseph Gardner, Founder, received a compensation package of $1M, which increased by 5% compared to previous year. 41% of the compensation package, or $410K, was in salary.
Michael Rogers, Chief Financial Officer, earned $891K in 2018, a 17% decrease compared to previous year.
Kevin Peters, Chief Medical and Scientific Officer, received $733K in 2018.
Regina Marek, VP Finance, Principal Financial and Accounting Officer, earned $302K in 2018.
Related executives
Kevin Peters
Aadi Bioscience
Chief Medical and Scientific Officer
Regina Marek
Aadi Bioscience
VP Finance, Principal Financial and Accounting Officer
Stephen Hoffman
Aadi Bioscience
Chief Executive Officer
Michael Rogers
Aadi Bioscience
Former Chief Financial and Business Officer
Joseph Gardner
Aadi Bioscience
Former President and Principal Executive Officer
You may also like
Source: SEC filing on April 27, 2020.